The company
iBio, Inc.
IBIO · Nasdaq
IBIO stood above a rising 150-day average in 20 of the last 52 weekly readings, and has been out of that trend for the last 26 weeks. It is 50.9% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 26
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $196K
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 56 (+6)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 20 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Marc BanjakChief Legal Officer | bought | 12,500at $1.64 | 26 Mar 2026filed 27 Mar 2026 |
| Marc BanjakChief Legal Officer | bought | 1,434at $1.76 | 26 Mar 2026filed 27 Mar 2026 |
| Martin BrennerDirector, Officer | bought | 12,336at $2.02 | 19 Mar 2026filed 23 Mar 2026 |
| Felipe DuranChief Financial Officer | bought | 24,835at $2.02 | 19 Mar 2026filed 23 Mar 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Affinity Asset Advisors, LLCadded · filed 13 Aug 2026 | 4,007,881$7.0M | +900,681+29.0% |
| Cormorant Asset Management, LPnew · filed 14 Aug 2026 | 3,570,000$6.2M | +3,570,000 |
| SILVERARC CAPITAL MANAGEMENT, LLCadded · filed 13 Aug 2026 | 3,520,490$6.2M | +3,294,490+1457.7% |
| Vestal Point Capital, LPnew · filed 14 Aug 2026 | 2,600,000$4.5M | +2,600,000 |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 2,098,151$3.7M | +1,009,852+92.8% |
| Frazier Life Sciences Management, L.P.unchanged · filed 14 Aug 2026 | 1,953,467$3.4M | 00.0% |
| Ensign Peak Advisors, Incnew · filed 14 Aug 2026 | 1,832,457$3.2M | +1,832,457 |
| Woodline Partners LPnew · filed 14 Aug 2026 | 1,776,547$3.1M | +1,776,547 |
| MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026 | 1,651,473$2.9M | +101,623+6.6% |
| CITADEL ADVISORS LLCadded · filed 14 Aug 2026 | 1,384,029$2.4M | +427,600+44.7% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.